Interference No. 103,995 Paper 29 Morel v. Sekhar Page 16 39. Table I in Sekhar ‘513 describes elemental zirconium and elemental boron reacting to form zirconium diboride (SDEx 3, c. 5, l. 30). 40. Table V in Sekhar ‘513 describes examples of micropyretic slurries, including slurries containing zirconium, i.e., samples 5 and 12. Sample 5 contains 10 g powder/ 6ml carrier. The carrier is 100 vol % colloidal silica and the powder is 50 wt% SiC, 5 wt% ZrB , 2 2 wt% Y O , 20 wt% Ti, and 23 wt% Ni. Sample 12 contains 10 g powder/ 5 ml carrier. 2 3 The carrier is 100 vol % mono-aluminum phosphate and the powder is 90 wt% SiC, 4 wt% Zr, 2.5 wt% Y O , 2.5 wt% Al O and2 3 2 3 1 wt% B. (SDEx 3, cc. 9-10, TABLE V, samples 5 and 12). 41. Example V in Sekhar ‘513 describes a slurry containing 25 g TiB , 10 g Ti and 2 5 g B in 15 ml colloidal alumina (SDEx 3, c. 10, ll. 50-53). Morel has already conceded that Morel claims 1, 3, 4, 6 and 9 are anticipated by Sekhar ‘513 (SDEx 3) (fact 34, p. 14 above). Morel argues that Morel claim 5 is not anticipated by Sekhar ‘513 because it depends on Morel claim 2 which is not alleged to be anticipated by Sekhar ‘513 (Paper 20, p. 2). Initially, we note that the various captions used by Sekhar in Sekhar preliminary motion 1 raise some confusion as to whether or not Sekhar intended to argue that Morel 3 claim 2 is anticipated by Sekhar ‘513 (SDEx 3). However, Sekhar does not address 3Sekhar preliminary motion 1 alleges that (i) “Claims 1, 3-6, 9 of the Morel Patent Are Unpatentable Under the Provisions of 35 U.S.C. § 102 Over Sekhar et al., U.S. Patent No. 5,364,513" (Paper 17, TABLE OF CONTENTS). (ii) “Further, claims 1, 3-5 and 9 of Morel are anticipated under 35 U.S.C. § 102 or, in the alternative, obvious under 35 U.S.C. § 103 over Sekhar et al., U.S. Patent No. 5,364,513 (Sekhar et al. ‘513)” (Paper 17, p. 1). (iii) “Specifically, the parties Sekhar et al. request the following precise relief from the Board ofPage: Previous 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 NextLast modified: November 3, 2007